UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions

Current oncology reports, 2020-10, Vol.22 (12), p.125-125, Article 125

2020

Volltextzugriff (PDF)

Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context

Blood advances, 2021-08, Vol.5 (15), p.3047-3052

2021

Volltextzugriff (PDF)

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2019-10, Vol.20 (10), p.e566-e581

2019

Volltextzugriff (PDF)

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Blood, 2013-05, Vol.121 (22), p.4439-4442

2013

Volltextzugriff (PDF)

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America

Blood advances, 2023-09, Vol.7 (18), p.5202-5209

2023

Volltextzugriff (PDF)

Treatment of cancer and thrombosis: practical approach

Revista de investigacion clinica, 2013-03, Vol.65 (2), p.174-182

2013

Volltextzugriff (PDF)

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

The lancet oncology, 2022-07, Vol.23 (7), p.e334-e347

2022

Volltextzugriff (PDF)

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd

British journal of haematology, 2017-10, Vol.179 (2), p.219-228

2017

Volltextzugriff (PDF)

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENEST xtnd

British journal of haematology, 2017-10, Vol.179 (2), p.219-228

2017

Volltextzugriff (PDF)

Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA)

Cancer medicine (Malden, MA), 2018-06, Vol.7 (6), p.2423-2433

2018

Volltextzugriff (PDF)

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

Blood advances, 2021-12, Vol.5 (23), p.4855-4863

2021

Volltextzugriff (PDF)

Unusual Morphologic Presentations of Blastic Plasmacytoid Dendritic Cell Neoplasm: Report of Two Cases Misdiagnosed as Melanoma and Leprosy

International journal of surgical pathology, 2014-02, Vol.22 (1), p.76-82

2014

Volltextzugriff (PDF)

Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study

Blood, 2015-12, Vol.126 (23), p.344-344

2015

Volltextzugriff (PDF)

Molecular Status Evaluation in a Standardized Laboratory in a Cohort of Patients with Chronic Myeloid Leukemia At the Instituto Mexicano Del Seguro Social (IMSS)

Blood, 2012-11, Vol.120 (21), p.4452-4452

2012

Volltextzugriff (PDF)

ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)

Blood, 2013-11, Vol.122 (21), p.4009-4009

2013

Volltextzugriff (PDF)

Cytogenetics As a Prognostic Factor Of The Overall Survival (OS) Of Mexican Patients With Myelodysplastic Syndrome (MDS)

Blood, 2013-11, Vol.122 (21), p.5236-5236

2013

Volltextzugriff (PDF)

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Blood, 2014-12, Vol.124 (21), p.4542-4542

2014

Volltextzugriff (PDF)

Diagnosis of lupus anticoagulant in the lupus anticoagulant‐hypoprothrombinemia syndrome: Report of two cases and review of the literature

American journal of hematology, 2002-11, Vol.71 (3), p.200-207

2002

Volltextzugriff (PDF)

Current Patient Management of Chronic Myeloid Leukemia in Latin America: A Study by the Latin American Leukemia Net (LALNET)

Cancer, 2010-11, Vol.116 (21), p.4991-5000

2010

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(68)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(23)
Hematology
(14)
Male
(13)
Female
(12)
Aged
(10)
Adult
(8)
Middle Aged
(8)
Adolescent
(6)
Oncology
(6)
Aged, 80 And Over
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Chronic Myeloid Leukemia
(5)
Mexico
(5)
Thrombosis
(5)
Latin America
(4)
Leukemia
(4)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(4)
Biological And Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America

ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America

Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions

Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

Acute Myeloid Leukemia in Mexico: The Specific Challenges of a Developing Country. Results From a Multicenter National Registry

Treatment of cancer and thrombosis: practical approach

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENEST xtnd

Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA)

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

Unusual Morphologic Presentations of Blastic Plasmacytoid Dendritic Cell Neoplasm: Report of Two Cases Misdiagnosed as Melanoma and Leprosy

Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study

Molecular Status Evaluation in a Standardized Laboratory in a Cohort of Patients with Chronic Myeloid Leukemia At the Instituto Mexicano Del Seguro Social (IMSS)

ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)

Cytogenetics As a Prognostic Factor Of The Overall Survival (OS) Of Mexican Patients With Myelodysplastic Syndrome (MDS)

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Diagnosis of lupus anticoagulant in the lupus anticoagulant‐hypoprothrombinemia syndrome: Report of two cases and review of the literature

Current Patient Management of Chronic Myeloid Leukemia in Latin America: A Study by the Latin American Leukemia Net (LALNET)

Suchergebnisse filtern